No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
MGX Metagenomi Technologies, LLC
- 3.880
- -0.330-7.84%
Close Jun 18 16:00 ET
- 4.020
- +0.140+3.61%
Post 17:48 ET
145.36MMarket Cap-1881P/E (TTM)
4.380High3.800Low124.57KVolume4.330Open4.210Pre Close505.92KTurnover1.99%Turnover RatioLossP/E (Static)37.46MShares12.74052wk High0.53P/B24.25MFloat Cap3.80052wk Low--Dividend TTM6.25MShs Float12.740Historical High--Div YieldTTM13.78%Amplitude3.800Historical Low4.061Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
EMERYVILLE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive
Express News | HC Wainwright & Co. Reiterates Buy on Metagenomi, Maintains $10 Price Target
Express News | Metagenomi Technologies LLC : Jefferies Cuts Target Price to $21 From $22
Express News | Metagenomi Q1 2024 Adj EPS $(1.19) Misses $(0.78) Estimate
Express News | Metagenomi Inc: Cash Runway Anticipated to Support Anticipated Operating Plans Into 2027
Metagenomi Technologies, LLC | 10-Q: Quarterly report
Comments
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
